Hartmut Pohl

is an Application Scientist with Enzo Life Sciences. He is a Cellular Neurobiologist and previously worked on the cellular mechanisms of demyelination in leading research groups at the ETH Zurich, Switzerland; Cambridge University, UK; and the Centre for Multiple Sclerosis, Barcelona, Spain.